An artificial intelligence (AI)-based study of home monitoring for neovascular age-related macular degeneration (AMD) ...

The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

There are various factors that may potentially increase the risk of developing AMD, such as advancing age (over 50); having a ...

Light therapy could be a useful treatment for the most common form of age-related macular degeneration, a new study says.

Safety Review Committee (SRC) approves single ascending dose 4mg cohort in Phase 1 trial of PMC-403, preparing for multiple ascendi ...

The fight against Age Related Molecular Degeneration Market is seeing a promising boost. According to a recent analysis, the ...

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

A recent study, published in the journal Nature looked into the six-month impact of switching to faricimab instead of ...

A new study published in the Journal of American Medical Association showed that rare instances of noninfectious intraocular ...

To date, Vabysmo is approved in more than 100 countries for DME and wet, or neovascular, age-related macular degeneration ...